BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21832017)

  • 1. Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses.
    Ducatez MF; Cai Z; Peiris M; Guan Y; Ye Z; Wan XF; Webby RJ
    J Clin Microbiol; 2011 Oct; 49(10):3531-6. PubMed ID: 21832017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
    Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic analysis of H5N1 highly pathogenic avian influenza viruses circulating in Egypt (2006-2012).
    Ibrahim M; Eladl AH; Sultan HA; Arafa AS; Abdel Razik AG; Abd El Rahman S; El-Azm KI; Saif YM; Lee CW
    Vet Microbiol; 2013 Dec; 167(3-4):651-61. PubMed ID: 24139721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.
    Ibrahim M; Sultan HA; Razik AG; Kang KI; Arafa AS; Shehata AA; Saif YM; Lee CW
    Vaccine; 2015 May; 33(23):2670-7. PubMed ID: 25910922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
    Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011.
    El-Shesheny R; Kayali G; Kandeil A; Cai Z; Barakat AB; Ghanim H; Ali MA
    J Gen Virol; 2012 Dec; 93(Pt 12):2564-2574. PubMed ID: 22956735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from poultry in India, 2006-2015.
    Bhat S; Nagarajan S; Kumar M; Murugkar HV; Kalaiyarasu S; Venkatesh G; Tosh C
    Arch Virol; 2017 Feb; 162(2):487-494. PubMed ID: 27812833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and antigenic characterization of H5N1 viruses of clade 2.3.2.1 isolated in India.
    Bhat S; Bhatia S; Pillai AS; Sood R; Singh VK; Shrivas OP; Mishra SK; Mawale N
    Microb Pathog; 2015 Nov; 88():87-93. PubMed ID: 26299902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor specificity and erythrocyte binding preferences of avian influenza viruses isolated from India.
    Pawar SD; Parkhi SS; Koratkar SS; Mishra AC
    Virol J; 2012 Oct; 9():251. PubMed ID: 23110802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemagglutination inhibition test for retrospective diagnosis of avian influenza in mammals].
    Kurskaia OG; Durymanov AG; Sharshov KA; Zaĭkovskaia AV; Shestopalov AM; Il'icheva TN
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (5):75-9. PubMed ID: 20063797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cross-clade monoclonal antibodies against H5N1 highly pathogenic avian influenza virus and their application to the antigenic analysis of diverse H5 subtype viruses.
    Gronsang D; Bui AN; Trinh DQ; Bui VN; Nguyen KV; Can MX; Omatsu T; Mizutani T; Nagai M; Katayama Y; Thampaisarn R; Ogawa H; Imai K
    Arch Virol; 2017 Aug; 162(8):2257-2269. PubMed ID: 28405766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.
    Wu WL; Chen Y; Wang P; Song W; Lau SY; Rayner JM; Smith GJ; Webster RG; Peiris JS; Lin T; Xia N; Guan Y; Chen H
    J Virol; 2008 Feb; 82(4):1798-807. PubMed ID: 18077726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses.
    Velumani S; Ho HT; He F; Musthaq S; Prabakaran M; Kwang J
    PLoS One; 2011; 6(6):e20737. PubMed ID: 21695200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
    Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
    Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics, Longevity, and Cross-Reactivity of Antineuraminidase Antibody after Natural Infection with Influenza A Viruses.
    Changsom D; Jiang L; Lerdsamran H; Iamsirithaworn S; Kitphati R; Pooruk P; Auewarakul P; Puthavathana P
    Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.
    Bihari I; Pánczél G; Kovacs J; Beygo J; Fragapane E
    Clin Vaccine Immunol; 2012 Dec; 19(12):1943-8. PubMed ID: 23081815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.
    Höschler K; Gopal R; Andrews N; Saville M; Pepin S; Wood J; Zambon MC
    Influenza Other Respir Viruses; 2007; 1(5-6):199-206. PubMed ID: 19453427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of monoclonal antibodies against the hemagglutinin of H5N1 and antigenic investigation of avian influenza H5N1 viruses isolated from China.
    Wei J; Yan B; Chen Z; Li T; Deng F; Wang H; Hu Z
    Can J Microbiol; 2011 Jan; 57(1):42-8. PubMed ID: 21217796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.